223 related articles for article (PubMed ID: 30986062)
41. Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor.
Park JB
PLoS One; 2016; 11(3):e0150392. PubMed ID: 26986569
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and Evaluation of Novel Benzofuran Derivatives as Selective SIRT2 Inhibitors.
Zhou Y; Cui H; Yu X; Peng T; Wang G; Wen X; Sun Y; Liu S; Zhang S; Hu L; Wang L
Molecules; 2017 Aug; 22(8):. PubMed ID: 28805748
[TBL] [Abstract][Full Text] [Related]
43. Molecular docking and dynamics simulation, receptor-based hypothesis: application to identify novel sirtuin 2 inhibitors.
Sakkiah S; Thangapandian S; Park C; Son M; Lee KW
Chem Biol Drug Des; 2012 Aug; 80(2):315-27. PubMed ID: 22564257
[TBL] [Abstract][Full Text] [Related]
44. In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents.
Ibrahim MAA; Abdeljawaad KAA; Roshdy E; Mohamed DEM; Ali TFS; Gabr GA; Jaragh-Alhadad LA; Mekhemer GAH; Shawky AM; Sidhom PA; Abdelrahman AHM
Sci Rep; 2023 Feb; 13(1):2146. PubMed ID: 36750593
[TBL] [Abstract][Full Text] [Related]
45. Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors.
Sun Y; Shan Y; Li C; Si R; Pan X; Wang B; Zhang J
Eur J Med Chem; 2017 Dec; 141():373-385. PubMed ID: 29032031
[TBL] [Abstract][Full Text] [Related]
46. Unexpected small molecules as novel SIRT2 suicide inhibitors.
Chen X; Zou Y; Wang J; Cao Z; Liu J; Li Y; Zhao Y; He B
Bioorg Med Chem; 2020 Mar; 28(6):115353. PubMed ID: 32061485
[TBL] [Abstract][Full Text] [Related]
47. Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines.
Alcolea V; Plano D; Karelia DN; Palop JA; Amin S; Sanmartín C; Sharma AK
Eur J Med Chem; 2016 May; 113():134-44. PubMed ID: 26922233
[TBL] [Abstract][Full Text] [Related]
48. Biological evaluation of 2-pyrazolinyl-1-carbothioamide derivatives against HCT116 human colorectal cancer cell lines and elucidation on QSAR and molecular binding modes.
Kim BS; Shin SY; Ahn S; Koh D; Lee YH; Lim Y
Bioorg Med Chem; 2017 Oct; 25(20):5423-5432. PubMed ID: 28811071
[TBL] [Abstract][Full Text] [Related]
49. Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells.
Hamaidi I; Zhang L; Kim N; Wang MH; Iclozan C; Fang B; Liu M; Koomen JM; Berglund AE; Yoder SJ; Yao J; Engelman RW; Creelan BC; Conejo-Garcia JR; Antonia SJ; Mulé JJ; Kim S
Cell Metab; 2020 Sep; 32(3):420-436.e12. PubMed ID: 32768387
[TBL] [Abstract][Full Text] [Related]
50. Identification of a Selective SIRT2 Inhibitor and Its Anti-breast Cancer Activity.
Shah AA; Ito A; Nakata A; Yoshida M
Biol Pharm Bull; 2016; 39(10):1739-1742. PubMed ID: 27725455
[TBL] [Abstract][Full Text] [Related]
51. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
Yoon YK; Ali MA; Wei AC; Shirazi AN; Parang K; Choon TS
Eur J Med Chem; 2014 Aug; 83():448-54. PubMed ID: 24992072
[TBL] [Abstract][Full Text] [Related]
52. Structure-based discovery of new selective small-molecule sirtuin 5 inhibitors.
Liu S; Ji S; Yu ZJ; Wang HL; Cheng X; Li WJ; Jing L; Yu Y; Chen Q; Yang LL; Li GB; Wu Y
Chem Biol Drug Des; 2018 Jan; 91(1):257-268. PubMed ID: 28756638
[TBL] [Abstract][Full Text] [Related]
53. Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine-(thio)urea hybrids as potential kinase inhibitors.
Türe A; Kahraman DC; Cetin-Atalay R; Helvacıoğlu S; Charehsaz M; Küçükgüzel İ
Comput Biol Chem; 2019 Feb; 78():227-241. PubMed ID: 30579980
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents.
Liu S; Louie MC; Rajagopalan V; Zhou G; Ponce E; Nguyen T; Green L
Bioorg Med Chem Lett; 2015 Mar; 25(6):1301-5. PubMed ID: 25701251
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety.
Koca İ; Özgür A; Coşkun KA; Tutar Y
Bioorg Med Chem; 2013 Jul; 21(13):3859-65. PubMed ID: 23664495
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
Huang X; Huang R; Liao Z; Pan Y; Gou S; Wang H
Eur J Med Chem; 2016 Jan; 108():381-391. PubMed ID: 26706349
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis, and biological evaluation of novel substituted thiourea derivatives as potential anticancer agents for NSCLC by blocking K-Ras protein-effectors interactions.
Zhang Y; Meng X; Tang H; Cheng M; Yang F; Xu W
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):344-353. PubMed ID: 31851852
[TBL] [Abstract][Full Text] [Related]
58. A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors.
Yang J; Cassel J; Boyle BC; Oppong D; Ahn YH; Weiser BP
PLoS One; 2024; 19(6):e0305000. PubMed ID: 38913635
[TBL] [Abstract][Full Text] [Related]
59. AK-1, a specific SIRT2 inhibitor, induces cell cycle arrest by downregulating Snail in HCT116 human colon carcinoma cells.
Cheon MG; Kim W; Choi M; Kim JE
Cancer Lett; 2015 Jan; 356(2 Pt B):637-45. PubMed ID: 25312940
[TBL] [Abstract][Full Text] [Related]
60. Opening the Selectivity Pocket in the Human Lysine Deacetylase Sirtuin2 - New Opportunities, New Questions.
Robaa D; Monaldi D; Wössner N; Kudo N; Rumpf T; Schiedel M; Yoshida M; Jung M
Chem Rec; 2018 Dec; 18(12):1701-1707. PubMed ID: 29931800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
